About: Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1996 (uk) article scientifique publié en 1996 (fr) im Jahr 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1996 (ast) artikull shkencor i botuar më 01 janar 1996 (sq) scientific article published on 01 January 1996 (en)
publication date	wds:Q71598414-C0529BE1-BC5D-4873-A118-8EE9567F7DB3
publication date	1996-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71598414-0C1F190C-1FEC-453A-8AE6-1A10DD4CC24D wds:Q71598414-3300A9CE-ED44-498A-9ED0-132EEDF1A020 wds:Q71598414-6531AF06-A43A-4EE6-A99E-4BE0625E1DE6 wds:Q71598414-835A3877-3085-4CA6-9E65-24D7AD5DB393 wds:Q71598414-977605E6-83C9-4B31-BEC1-A8A1E63DE0A1 wds:Q71598414-C5951A2B-764C-4EB5-B732-4F43D0925EF3
author name string	K Hara K Abe S Kohno J Kadota O Sakito R Shirai
rdfs:label	Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (en) Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (nl) Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (sq)
skos:prefLabel	Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (en) Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (nl) Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (sq)
name	Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (en) Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (nl) Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (sq)
title	wds:Q71598414-7C8C0A08-DCBD-49B5-9626-31ADD40C7F97
title	Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy (en)
page(s)	wds:Q71598414-FDA09419-9FA5-4ABE-9781-77F50C97C348
page(s)	42-48
instance of	wds:Q71598414-BCEEAE51-498F-4E38-A868-A4DFBACFBF44
instance of	scholarly article
main subject	wds:Q71598414-8F163E74-4869-4A91-878D-C77B7270CBF1 wds:Q71598414-A90E8804-A97E-4B2E-B220-C4A5C33897F3
main subject	diffuse panbronchiolitis bronchoalveolar lavage
PubMed ID	wds:Q71598414-8E206EA0-3FE9-42EA-8100-3CD4826D55D0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8833992
PubMed ID	8833992
published in	wds:Q71598414-C1C43764-B38E-412B-9152-A6481994C95F
published in	Respiration
issue	wds:Q71598414-0D6773C0-A155-4685-A693-B43C4B8EA0E9
volume	wds:Q71598414-F46BB8ED-20E1-4DAA-B3A3-231841DF2772
issue	1
volume	63
DOI	wds:Q71598414-BDE12179-1D55-41F6-BE93-E346204C7EB2
DOI	http://dx.doi.org/10.1159/000196514
DOI	10.1159/000196514
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71598414
is cites work of	Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial Long-term azithromycin may improve lung function in children with cystic fibrosis Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells Mechanisms of action and clinical application of macrolides as immunomodulatory medications Pharmacotherapy of severe asthma Anti-inflammatory effects of macrolide antibiotics Shifting the balance: antibiotic effects on host-microbiota mutualism Role of macrolide therapy in chronic obstructive pulmonary disease Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis Efficacy of periprosthetic erythromycin delivery for wear debris-induced inflammation and osteolysis Thrombin induces NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells by a Rac1-dependent PI3K/Akt pathway [Anti-inflammatory effects of macrolides: applications in lung disease] Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? Antimicrobial and Immunologic Activities of Clarithromycin in a Murine Model of Mycoplasma pneumoniae -Induced Pneumonia Effect of roxithromycin on T lymphocyte proliferation and cytokine production elicited by mite antigen Diffuse panbronchiolitis--pathophysiology and treatment mechanisms Roxithromycin promotes lymphocyte apoptosis in Dermatophagoides-sensitive asthma patients Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids. Inhibitory effect of erythromycin on interleukin 8 production by 1 alpha,25-dihydroxyvitamin D3-stimulated THP-1 cells. Grepafloxacin inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in human airway epithelial cells [Macrolides and Pseudomonas aeruginosa infection] The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms. Autoinflammatory Disease in the Lung. Characterization of CD44 expressed on alveolar macrophages in patients with diffuse panbronchiolitis Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors Inhibitory effect of erythromycin on superoxide anion production by human neutrophils primed with granulocyte-colony stimulating factor Macrolides, asthma, inflammation, and infection Macrolides for Acute Wheezing Episodes in Preschool Children Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa Short-term roxithromycin treatment attenuates airway inflammation via MAPK/NF-κB activation in a mouse model of allergic asthma Macrolides in the respiratory tract in cystic fibrosis. Diffuse panbronchiolitis in a patient with common variable immunodeficiency: a casual association or a pathogenetic correlation? Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB) Effect of clarithromycin on inflammatory markers in patients with atherosclerosis Different Responses to Clarithromycin in Patients with Cryptogenic Organizing Pneumonia
is cites work of	wds:Q36779660-EFBC12AE-E68F-4810-8833-86C300A42FAE wds:Q36815073-84762B22-0274-491A-A75B-A813B3AD08B2 wds:Q52540442-855BA493-49CE-40B7-9EF4-55EE5FF8CA86 wds:Q34430671-F379A151-20E7-400F-994F-D3DF791B4AB4 wds:Q43613347-2E887981-293D-46B8-9DF3-73CEA6DF00BF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software